intuit surgic monopoli robot surgeri come
end wide moat still intact
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
star align perfectli intuit surgic
compani continu gain momentum gener surgeri
hernia colorect procedur enjoy robust growth
meanwhil matur procedur dvp dvh enjoy
unexpect renaiss larg due factor unlik repeat
total procedur growth highest level decad
total volum half intuit perform
defi expect howev anticip challeng
part due slowdown larg factor
gener moder procedur capit placement
deceler long-term posit view compani
competit posit howev unchang
consid long-term thesi compani particularli
conserv even compani procedur volum
exceed million think total address global market
sever time size still offer firm ampl growth
opportun particularli oversea ultim ceil robot
surgeri virtual unlimit exist applic
scratch surfac possibl procedur could migrat
robot number categori still offer sizabl unpenetr
under-penetrated opportun outsid unit
state robot surgeri accept develop
world significantli lower absenc
formid competitor recent
continu domin robot surgeri arena
believ growth start deceler number
procedur penetr rate hit ceil also
believ compani increasingli run manual
laparoscopi low-cost robotic-assist surgeri viabl
altern high-volum procedur appendectomi
need focu tangibl robot surgeri benefit evid
clinic econom compani increasingli reli
growth intern seen skeptic
past sale growth probabl never reach rate
past compani still ampl opportun
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
intuit surgic develop produc market robot system
assist minim invas surgeri also provid instrument
dispos accessori warranti servic system compani
place da vinci system hospit world-wide
instal unit state grow number emerg
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
rais fair valu estim per share
even moder expect due
anticip moder pullback
procedur growth notabl system sale
current year owe impact pandem
patient volum hospit budget long-term
forecast procedur system penetr rate
growth compound annual growth rate
driven gener surgeri matur procedur
deceler
compani strong perform gener surgeri
continu exceed forecast hernia particular
stay strong gener surgeri largest categori
volum procedur annual
still forecast healthi expans total volum
grow doubl digit averag next decad
also surpris continu strength
gynecolog urolog still view
sustain long term deceler
overal hysterectomi market like continu
hysterectomi like caus dvh struggl
expand penetr rate beyond current level
project benign dvh volum grow
singl digit throughout long-term forecast overal
 procedur growth rate averag high singl digit
throughout forecast outsid
expect growth rate doubl level
expect system placement deceler opinion
sizabl portion instal platform absorb
addit procedur util rate go
averag sell price like pressur new
entrant forecast system sale midsingl
digit instrument servic revenu expect grow
rapidli around per year line procedur
expect adjust oper margin stay
rang entir forecast impli mid-teen
growth oper incom period
margin expans trajectori slower intuit
abl deliv recent believ sever factor
slow expans futur mix toward
lower-pr procedur roll lower-pr
platform carri lower margin eventu pressur
competit
virtual upsid limit valuat
compani fate tie size procedur market
abl penetr marketplac million
procedur main reason firm almost
alway command lofti valuat multipl bull
case expect firm total procedur volum grow
million would boost
revenu compound-annual-growth-rate teen forecast oper
margin grow minim compani maintain
price structur face competit fair valu
estim jump per share forecast
consid scenario highli unlik
downsid could see persist volum
moder due chang patient behaviour
downward pressur dvp flatten dvh
lose share laparoscopi procedur fail
make much ground procedur compound-annual-growth-rate stay
around system revenu declin part owe
competit pressur instrument servic revenu
rise midsingl digit margin also
pressur valuat drop per share
given wide rang outcom believ high
uncertainti rate appropri
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
intuit possess new competitor convinc
enough hospit purchas trial instrument
extens period train robot-na da vinci-train
surgeon recruit will patient howev
certain compet instrument -- price attract
may make inroad procedures/speci current
under-penetrated intuit particularli hospit
balk da vinci cost intuit respond
threat expand platform roster includ lower-cost
altern well offer oper leas soften
high price sticker impact
cost becom exorbit averag system price
around million repres larg portion typic
would need compel technolog price differ
switch machin wear natur
upgrad cycl around five eight year given need
purchas new instrument procedur instal
system provid rel depend stream
revenu per procedur long surgeon continu use
biggest threat intuit moat futur robot
surgeri gener plausibl cash-strap
hospit receiv addit reimburs robot
usag may opt plod yet cheaper altern
manual laparoscopi particularli clinic bodi work
support robot surgeri tradit mi lack
also plausibl robot surgeri may face applic
limit consid number variou
procedur alreadi perform da vinci seem
unlik final anticip compani monopolist
posit come end mani new entrant
challeng firm anticip margin
competit pressur time intuit could
encount formid competit like
expand instal base da vinci
system vast procedur databas think intuit
surgic dug wide moat around busi
system instrument price reflect firm monopoli
statu nich allow achiev
profit rare enjoy medic equip maker
adjust oper margin fact
gross margin intuit system compar
instrument consum compon profit
distinct industri consum typic
rare attract rapidli grow market
robot surgeri stay impenetr competit
long firm monopoli sooner later
ceas exist sever emerg competitor
none potenti significantli disrupt firm
oper erod return capit intuit
intellectu properti
system grow
instrument base sizabl barrier
ever-grow clinic databas present biggest
challeng new entrant amass bodi data
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
moat trend stabl stage game intuit
surgic meaning direct competitor
extend definit competit includ manual
laparoscopi intuit abil expand competit
domin becom less clear compani virtual
unchalleng robot surgeri field
increasingli run manual surgeri particularli
ventur outsid core surgic area switch
cost anoth robot high hospit custom
term money train surgeon switch manual
lap done significantli less effort given
surgeon familiar mi forecast
procedur overal convert robot surgeri
next decad around procedur compound-annual-growth-rate
firm profit per procedur come
sever reason fewer greenfield opportun
 marketplac fulli satur lower averag sell
price dispos platform share
special challeng procedur sell cycl
intuit research develop product may also
start declin fewer procedur opportun
emerg innov cycl -- low-hang fruit
pick compani invest heavili
order penetr variou surgic special
outsid core market final see nois
competit front threat firm
moat might make certain procedur suscept
price pressur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth da vinci system assist multipl type
hospit drive procedur
intuit surgic potenti specialis rival
on-going high-margin instrument sale servic
revenu provid clinic case histori
sought surgeon hospit administr
ointuit surgic direct rival grow
base user build career
profici da vinci
owe may see emerg
competit particularli lower-cost procedur
oth firm averag utilis rate well
instal challeng hospit tri
maxim exist da vinci util
orobot gynaecolog like continu declin
forese futur along hysterectomi
gener owe gener overus
procedur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
intuit balanc sheet spotless zero debt
ampl cash compani could arguabl leverag
balanc sheet strict cash deploy polici limit
usag tuck-in acquisit reinvest share
buyback compani resum buy-back polici recent
could acceler need balanc sheet health
concern extrem limit
one key long-term risk
competitor introduc compel altern da vinci
procedur siphon intuit growth
opportun potenti reduc profit
busi particularli curiou foray
robot surgeri previous via joint ventur alphabet
solo littl known industri giant
work regard soft tissu surgeri
interest field alon worth monitor asid
competit factor could imped robot surgeri
rapid advanc robot surgeri yet establish
good altern manual laparoscopi certain
procedur benign hysterectomi well gener
surgeri reimburs distinguish
manual robot mi robot instrument cost
hospit forc eat differ
two procedur clinic benefit well
cost-consci hospit particularli outsid unit
state cautiou adopt da vinci
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
intuit surgic superb record come
organ growth return capit technolog
revolutionari testament intuit
vision manag team abil drive
adopt expand area
superb applaud compani dedic research
develop shield robust return
capit avers expans unrel area via
acquisit appropri share-buyback polici
appear slow compani share
reach lofti level stewardship rate exemplari
repres date owner name posit common share held report holder issuer
capit research manag compani
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
intuit challeng long-term
opportun still sizabl rais fve
rais fair valu estim intuit
per share even moder expect due
anticip moder pullback
procedur growth notabl system sale
current year owe impact pandem
patient volum hospit budget long-term
forecast procedur system penetr rate
compound annual growth rate driven
gener surgeri matur procedur deceler
 also see strong adopt ion wide-
moat rate firm remain intact even start
peak final see modest
upsid wide love stock
compani strong perform gener surgeri
continu exceed forecast hernia particular
stay strong gener surgeri largest categori
volum procedur year still
forecast healthi expans volum grow
doubl digit averag next decad davinci
becom ubiquit categori urolog
gynecolog also surpris
continu strength gynecolog urolog although
view sustain long term overal
 procedur growth rate averag high singl digit
throughout forecast outsid
expect growth rate doubl level
expect system placement deceler opinion
sizabl portion instal platform absorb
addit procedur util rate go
averag sell price like pressur new
entrant forecast system sale midsingl
digit instrument servic revenu expect grow
rapidli around per year line procedur
expect adjust oper margin stay
rang entir forecast impli mid-teen growth
oper incom period margin
expans trajectori slower intuit
abl deliv recent believ sever factor slow
expans futur mix toward lower-
price procedur roll lower-pr platform
lower margin eventu pressur
regard competitor remain unconvinc
intuit cede materi share soft tissu surgeri
like cambridg medic other
 bit wild card verb surgic ventur
get close releas platform
undoubtedli interest platform surgic
commun intuit moat well-protect
massiv amount clinic evid entrench
surgeon commun open revisit
expect see capabl ultrasecret
platform even uniqu featur
artifici intellig aid exampl forese
technolog gap persist intuit posit
better anyon far data collect robot
result week ago full number releas
lack meaning revel maintain
fair valu estim wide-moat rate
share slip result announc
still trade lofti level
interest element full disclosur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
compani cautiou tone pertain new
system sale sure inform
surpris anyon clear trade-in
elev level number quarter placement
fourth quarter trade-in number older
platform field like upgrad bound
decreas exactli intuit indic
unless compani roll next-gener platform
near futur expect system placement
reason growth trajectori futur perhap even
year-over-year declin howev evid
deterior compani growth prospect
view concern intuit competit
posit remain convinc even upcom
wave competit entri go threaten
intuit domin near- medium-term futur
growth particularli procedur
close decade-high
simpli
intuit preliminari number
intuit preliminari fourth-quart result larg
line estim trend present throughout
remain healthi level quarter result
full-year procedur growth
highest level sinc total number
procedur perform roughli one third current
volum make current result even remark
procedur guidanc show temper
nonetheless impress
await full-year result amend growth
forecast compani deliv procedur
growth rang given forecast call
growth increas fair valu estim
high-single-digit percentag valuat
wide-moat rate remain unchang share continu
trade lofti level
compani close full year growth
instrument accessori growth system
increas servic intuit ship platform
fourth quarter averag sell price
million notabl platform trade-in repres
unit sold second quarter row
trade-in roughli level greenfield
instal issu compani
grown instal base dramat benefit
replac cycl system growth like
constrain materi percentag si
instal base alreadi upgrad xi si entir instal
base repres roughli one quarter platform
greenfield opportun diminish new unit
growth quarter would challeng
intuit reach double-digit growth unit sale
solid third quarter intuit rais fve
intuit surgic procedur growth third quarter
surpass alreadi strong perform first half
volum growth quarter allow firm boost
full-year guidanc adjust forecast
well think growth procedur drive
unpreced momentum continu
absenc macroeconom
moder factor result boost near-term
forecast instrument system servic
revenu expect larg unchang rais
fair valu estim per share consid
share current level expens retain wide
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
procedur growth unit state remark
outsid line
histor number driver growth remain
larg gener surgeri maintain torrid
adopt pace although cholecystectomi bump
unexpect matur gynecolog grew
quarter uncharacterist baffl
even compani believ gener surgeri
remain strong hernia colorect adopt
opportun still sizabl continu anticip
moder even possibl pullback matur
revenu grew quarter total unit
placement instal base impli
uptick util intuit continu see materi
growth trade-in quarter new
instal actual last year trade-in
oper leas account half total
placement suggest penetr rate final
start subsid system mix revers first
quarter xi model place result
asp jump million quarter
intuit margin came line forecast
research
develop sale spend effort ion
diagnost platform market three unit sold
quarter well sp roll-out outlook
margin remain steadi acceler
beyond ion adopt pick
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
